National Cancer Institute
Cancer Imaging Program
Print Friendly Version | Text Only | Contact Us  
Home
About CIP
Research Funding
Programs & Resources
 
Specialized Initiatives
 
Information Systems
 
Ultrasound Research Interface
 
Bioinformatics & Bioengineering
 
Funded Research
 
NIH Roadmap
Clinical Trials
Reports & Publications
News & Meetings
Imaging Information
Imaging Guidelines
Programs & Resources
Development of Clinical Imaging Drugs & Enhancers (DCIDE)
Introduction
Opportunity
Program
Scope
Process
Requests for Support
Evaluation Criteria
Intellectual Property & Industrial Intervention
Assessment & Oversight
Metrics for Judging Success
Additional Sources of Information
FAQs
Approved DCIDE Projects
Evaluation Criteria

Stage I: Scientific Merit (non-NCI reviewers):

  • Strength of scientific evidence and hypothesis
  • Certification (biochemical or physiological validation)
  • Potential clinical impact
  • Feasibility
  • Novelty

Stage II: Operational Feasibility (NCI staff):

  • Resource availability
  • Potential impact on current or proposed clinical trials by NCI
  • Magnitude of required pre-clinical studies to address scientific/regulatory issues
  • Resource intensity, i.e., costs and benefits

< Previous  |  Next Section >  Main

National Cancer InstituteDepartment of Health & Human ServicesNational Institutes of HealthFirstGov.gov